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Wegener’s granulomatosis presenting during
pregnancy with acute limb ischemia
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We report a rare case of a pregnant woman with Wegener’s granulomatosis whose disease involved the lungs, the spleen,
and a limb. Wegener’s granulomatosis was clinically manifested in the 34th week of pregnancy with pulmonary infiltrates,
splenic infarcts, and acute limb ischemia. Successive thrombectomies failed to maintain arterial flow in the distal limb due
to the development of active vasculitis. Thrombosis of the tibial arteries and recurrence of thrombosis was a persistent
clinical observation. In the meantime, a cesarean section was performed, with a successful delivery of a healthy male
newborn. Because of the recent cesarean section, the patient did not undergo thrombolysis. The woman finally underwent
amputation of the limb. According to the reviewed literature, this is the sixth reported case of Wegener’s granulomatosis
presenting with digital ischemia and the first manifested during pregnancy. (J Vasc Surg 2005;42:800-4.)Wegener’s granulomatosis (WG) is a systemic, necro-
tizing, small vessel vasculitis. Although Klinger reported
the first case in 1931, Friedrich Wegener in 1936 charac-
terized the unique clinical and pathologic features of this
disease that subsequently came to bear his name. We report
a rare case of a pregnant woman whose disease involved the
lungs, the spleen, and a limb. WG was clinically manifested
with pulmonary infiltrates, splenic infarcts, and acute limb
ischemia, which finally resulted in amputation of the gan-
grenous limb. Digital ischemia due to Wegener’s granulo-
matosis is an extremely rare manifestation and has not been
described with onset during pregnancy.
CASE REPORT
A 24-year-old woman in the 34th week of pregnancy pre-
sented in July 2004 with fever, nonproductive cough, episodes of
hemoptysis, and pain in the right leg for a duration of 12 days. She
complained of anorexia and fatigue, dating back to the last 20 days.
The woman had received treatment with amoxicillin as an outpa-
tient, with no clinical improvement. Her past medical history was
unremarkable. She denied any alcohol, tobacco, or illicit drug use.
She had had a previous uneventful pregnancy and a normal vaginal
delivery 20 months earlier.
The patient was initially admitted under the care of the De-
partment of Pneumonology of a district hospital. Routine hema-
tology investigations revealed hemoglobin, 9.5 g/dL; white blood
cell count, 11.700/mm3 (polymorphonuclear, 76.2%; lympho-
cytes, 13.1%; eosinophils, 1.3%; monocytes, 8.9%); erythrocyte
sedimentation rate (ESR), 130 mm/h; platelets, 420.000/mm3;
prothrombin time, 12.16 seconds; international normalized ratio,
0.98; partial thromboplastin time, 23.7 seconds; and C-reactive
protein (CRP), 90.5 mg/L. The biochemical investigation find-
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800ings were within normal reference values. A chest radiograph at
week 34 displayed bilateral parenchymal infiltrates (Fig 1).
The patient was commenced on intravenous ceftriaxone and
azithromycin. On day 3, the patient complained of worsening of
pain and paresthesia of the right foot with bluish mottling of the
skin. A color duplex scan revealed low flow velocity in the anterior
and posterior tibial arteries, and the woman was urgently trans-
ferred to the Department of Vascular Surgery of “Red Cross”
Hospital.
On admission to our department, the foot was ischemic, no
pulses were palpated in the femoral artery, and no flow was
detected with Doppler examination. The patient complained of
chest discomfort. Her blood pressure was 135/90 mm Hg, her
pulse rate was 90 beats/min, and her respiratory rate was 26
breaths/min. Blood gases revealed PO2, 54 mm Hg; PCO2, 43 mm
Hg; pH, 7.32, and arterial saturation of oxygen, 87%.
At 34 weeks gestation, with the presenting clinical picture of
acute limb ischemia combined with respiratory disease, the preg-
Fig 1. A chest radiograph displays bilateral parenchymal infil-
trates.nancy was considered to be high risk. The woman underwent an
occl
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anesthesia. During the procedure, the Fogarty catheter was passed
through the femoral arteriotomy and was advanced easily down the
popliteal trifurcation to the ankle level. Recent and pre-existing
well-organized thrombi were removed, and circulation was re-
stored in the distal limb, with palpable pulses on pedal arteries.
Heparin was not administrated to avoid excessive bleeding at the
subsequent caesarean section. A biopsy sample of the femoral
artery was sent for histologic examination. The removed thrombi
were sent for pathologic analysis. At the same time, a cesarean
section was performed with a successful delivery of a healthy male
newborn weighing 2050 g.
Twelve hours later, the woman experienced a recurrence of
acute thrombosis and severe ischemia in her right limb. An angio-
graphic examination was not available at that moment, and a
second urgent intervention was decided upon. Thrombectomy of
the popliteal artery was performed through an incision below the
knee. The popliteal trifurcation was explored, and thrombectomies
to the posterior tibial, anterior tibial, and peroneal arteries were
done. Restoration of palpable pulses in the posterior tibial artery
was achieved, and biphasic signals were recognized in the anterior
tibial artery during a Doppler ultrasound scan.
Twenty-four hours later, the patient presented again with a
recurrence of arterial occlusion in the same limb. The patient
underwent an urgent angiographic examination that demonstrated
occlusion of the popliteal artery (Fig 2). Because of the recent
cesarean section, the patient did not undergo thrombolysis. The
woman underwent a third operation, and during the procedure a
thrombectomy of the popliteal artery was possible (targeting to
limit the level of future amputation). Ten hours later, the arterial
axis below the knee was once more totally thrombosed.
Systemic anticoagulation therapy with heparin (5000 IU) was
given during the second and third operations. The patient was
commenced on low-molecular-weight heparin (tinzaparin sodium,
14.000 IU of antifactor Xa) after completion of the caesarean
section, which was continued in the same dose after the second and
third thrombectomy.
The patient received pharmaceutical therapy with vasodilating
Fig 2. Angiography displaysdrugs.A computerized tomography scan of the thorax and abdomen
showed nodular masses in both lungs, with diffuse interstitial
disease, positive findings on a bronchogram, dense atelectatic areas
in both lung bases (Fig 3), and multiple hypodense areas of the
spleen compatible with splenic infarcts (Fig 4).
The serologic examination revealed serum antineutrophil cy-
toplasmic antibodies (C-ANCA) positive at a titre of 1:640, Ab-
proteinase 3 (PR3), 6.4 ng/mL (normal levels, 2 ng/mL);
antimyeloperoxidase, negative; antinuclear antibodies positive at a
titre of 1:80; and antiscleroderma 70, negative. Serologic exami-
nation also included anticardiolipin antibodies immunoglobulin
(Ig) G: 6.5 antiphosolipid units/mL (GPLU) (normal levels,
15.0 GPLU/mL) and IgM, 8.3 MPLU/mL (normal levels,
15.0 MPLU/mL); anti-2-glycoprotein I: IgG, 5.0 standard
IgG units/mL (SGU) (normal levels,20.0 SGU/mL) and IgM,
7.6 standard IgM units/mL (SMU) (normal levels,20.0 SMU/
mL); antiextractable nuclear antigens, negative; anti-RNP, nega-
tive; anti-Sm, negative; anti-SSA/RO, negative; anti-SSB/La,
negative; and CRP, 90.6 mg/L. Values for complement factors
and IgG, IgM, IgA were in normal range. Results of urine exami-
nation and serum urea and creatinine were within normal levels.
Plasma lipids (cholesterol, low- and high-density-lipoprotein cho-
lesterol, and triglycerides) were within normal levels. The results of
a serology examination for deficiency of protein C and protein S,
AT III, and factor V Leiden were negative. Electrocardiogram and
cardiac ultrasonography examination results were normal, and an
examination by the ear-nose-throat clinic revealed no involvement
of the upper airway. Histologic examination of the femoral artery
biopsy was normal. Pathologic analysis of the thrombus initially
removed during the first surgical intervention was negative. The
patient declined a proposed lung biopsy. A complete ophthalmo-
logic examination was without pathologic findings.
According to the clinical, laboratory, and imaging findings, a
diagnosis of Wegener’s granulomatosis without renal involvement
was made, and the patient was commenced on standard treatment
consisting of prednisolone (1 mg/kg/day) and cyclophosphamide
(2 mg/kg/day), with dramatic recovery and improvement in her
usion of the popliteal artery.general condition.
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amputation of the gangrenous limb below the knee. Her postop-
erative course was uneventful. The patient was discharged 12 days
later.
A chest radiograph showed complete resolution of the previ-
Fig 3. Computerized tomography scan of the thorax
disease and dense atelectatic areas in both lung bases.
Fig 4. Computerized tomography of the abdomen rev
splenic infarcts.ously noted pulmonary abnormalities. Cyclophosphamide therapywas continued and the prednisolone dosage was gradually tapered
off. Laboratory examination showed a gradual decrement of ESR
to 10 mm/h, while the C-ANCA was negative (3 months after her
initial visit). The patient remained asymptomatic at the time this
report was written. Her baby developed pneumonia 4 months after
nodular masses in both lungs, with diffuse interstitial
ultiple hypodense areas of the spleen compatible withshowseals mdelivery. He recovered uneventfully, and at present, remains
JOURNAL OF VASCULAR SURGERY
Volume 42, Number 4 Besias et al 803healthy and within normal development growth curves between
the 10th and 25th percentile.
DISCUSSION
WG is a systemic, necrotizing, small-vessel vasculitis.
Vascular inflammation and occlusion leading to tissue isch-
emia is a hallmark of WG.1,2 Although much remains
unclear about the factors that initiate and perpetuate the
inflammatory process of WG, there is strong evidence that
immune mechanisms play an important role in the patho-
physiology of the disease. Untreated, the disease has been
reported to be fatal within a year of diagnosis in more than
80% of patients.3
The peak incidence of granulomatosis occurs in the
fourth and fifth decades and thus is rarely diagnosed in
women of childbearing age and is uncommonly encoun-
tered during pregnancy.4 Reports of pregnancy in patients
with WG are rare: 22 pregnancies in 18 patients with WG
have been reported in the literature since 1970. Talbot
et al5 reported the first case of WG with onset during
pregnancy. Apart from the present report, WG has been
diagnosed during pregnancy in seven cases that led to three
premature births,5-7 one normal-term birth,8 two thera-
peutic abortions,9,10 and one maternal death.11,12 Also, 15
pregnancies in 11 patients with known WG (active or in
remission at pregnancy onset) have been reported, with
various maternal and fetal outcomes.12,13
WG has a clinical predilection for the upper airways,
lungs, and kidneys. Ocular, gastrointestinal, cardiac, cuta-
neous, and splenic manifestations have been reported to
occur at the initial presentation or during the course of the
disease.14 This report concerns a pregnant woman whose
disease involved the lungs, the spleen, and a limb. WG was
clinically manifested with pulmonary infiltrates, splenic in-
farcts, and acute limb ischemia, which finally resulted in
amputation of the gangrenous limb.
According to the reviewed literature, this is the sixth
reported case of WG expressed with digital ischemia and
the first with ischemia manifested during pregnancy. In the
five previous reported cases, the ischemia was manifested
with gangrene of the toes, resulting to toe or transmetatar-
sal amputation.15-19 Splenic involvement in WG occurs
more frequently than once thought, and the clinical profile
includes spontaneous splenic rupture, hemorrhage, splenic
necrosis, and infarcts.20 Furthermore, until now, eight
cases of WG splenic infarcts have been reported in the
literature.20-22
The two most widely used systems—the 1990 Ameri-
can College of Rheumatology (ACR) classification and the
1994 Chapel Hill Consensus definitions (CHCC)—have
proposed criteria for the classification of WG based on
abnormal urinary sediment, abnormal findings on chest ra-
diography, presence of hemoptysis, oral ulcers or nasal dis-
charge, and granulomatous inflammation on biopsy.23,24
Sørensen et al25 have recently modified the diagnostic
criteria for WG based upon the CHCC definitions. A tissue
biopsy sample is not strictly required to make a diagnosis of
WG in the presence of a surrogate parameter for granulo-matous inflammation in the respiratory system, positive
PR3-ANCA, and lack of eosinophilia in the blood and
biopsy samples.25,26
The diagnosis of our patient was based on clinical,
imaging, and serologic examination. In the initial phase of
the diagnostic approach, we focused on eliciting the cause
of arterial thrombosis, as it is known that arterial occlusion
could result from primary thrombus formation in an artery
or due to embolization from a site elsewhere in the circu-
lation.27 Subjects known to carry acquired or inherited
thrombotic disorders, including neoplasmatic disorders, or
who use drugs which cause vasospasm, may also present
with arterial occlusion during pregnancy. No site of throm-
bus or embolus formation, or thrombotic disorder was
detected, however. Hemoptysis, granulomatous inflamma-
tion of the lungs confirmed by fixed bilateral infiltrates, lack
of eosinophilia in the blood, and positive titre 1:640 of
C-ANCA were strongly suggestive of the diagnosis.
The main ANCA target antigen in WG is PR3, a
neutrophil and monocyte-derived neutral serine protease,
which was found significantly elevated (Ab-PR3, 6.4 ng/
mL; normal levels, 2 ng/mL). WG, microscopic polyar-
teritis (MP), and Churg-Strauss syndrome (CSS) are systemic
vasculitis characterized by the presence of antineutrophil
cytoplasmic antibodies (ANCA). MP is a vasculitis associ-
ated with necrotizing glomerulonephritis and always affects
the kidneys. Antimyeloperoxidase (MPO)-ANCA are a typ-
ical feature of MP and CSS, while anti-PR3-ANCA are
highly specific for WG.28,29
Thrombosis of the tibial arteries and recurrence of
thrombosis was a persistent clinical observation confirmed
by the removal of recent and pre-existing thrombi during
the successive attempts of limb salvage. Thrombosis of the
femoral artery was a consequence of thrombosis of the tibial
arteries. In retrospect, taking into consideration the final
diagnosis, we can ascertain that the attempted surgical
interventions were not capable of deterring the catastrophic
outcome of limb amputation but did limit the level of
amputation. This last determination is derived from the fact
that the first thrombectomy restored the arterial flow in the
femoral artery, but the successive operations failed to main-
tain arterial flow in the distal limb due to the developing
active vasculitis that led to vascular wall inflammation and
occlusion.
The association of WG and pregnancy is rare and poses
unique therapeutic challenges. The reporting data regard-
ing pharmaceutical treatment of WG during pregnancy is
even more scant. Three of the seven cases that were initially
diagnosed during pregnancy were treated with cyclophosph-
amide (after completion of the first trimester) and normal
deliveries eventually resulted.5-7 In two cases, a therapeutic
abortion was followed by treatment with cyclophospha-
mide and prednisolone.9,10 In one woman, medication
with azathioprine resulted in maternal and fetal death,11
and in one case, successful remission of the disease during
the first trimester of pregnancy was achieved with the use of
intravenous immunoglobulin and steroids.
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therapy are the gestation of the pregnancy (specific regi-
mens may influence the critical period of fetus organogen-
esis in the first trimester of pregnancy) and the severity of
the disease. Cyclophosphamide has been considered the
most effective treatment especially in severe, life-threatening
forms of the disease, as a 75% complete remission and an
80% survival rate have been confirmed.14 It has, however,
been associated with spontaneous abortions and various
birth deformities when it is used during early pregnancy,
and so its administration is indicated when the disease
presents in the third and late second trimester of pregnancy.
Alternative therapeutic options include cyclosporine and
intravenous immunoglobulin, agents that can be used dur-
ing early pregnancy.8
The clinical presentation of WG can be diverse. The
disease requires preconceptual planning, careful clinical
management, and vigorous treatment in the case of active
disease.
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